Compare ResMed Inc. (RMD) vs Shopify Inc. (SHOP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Shopify Inc. — how do they compare? ResMed Inc. trades at $219.5 (market cap $31.73B), while Shopify Inc. trades at $127.02 (market cap $163.13B). The key difference: Shopify Inc. is far larger — about 5.1× ResMed Inc.'s market cap, and ResMed Inc. pays a 1.2% dividend while Shopify Inc. pays none. Which is the better fit depends on your goals.
| RMD | SHOP | |
|---|---|---|
Market Cap | $31.73B | $163.13B |
Sector | Health | Technology |
52-Week High | $283.28 | $179.01 |
52-Week Low | $182.82 | $95.40 |
Enterprise Value | $31.08B | $158.36B |
Dividend Yield | 1.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $221.05, down 3.2% on the day, with a bearish technical signal and key support at $218. The company reported strong Q4 2026 results, beating EPS estimates at $2.95, and maintains robust profitability with a 26.94% net income margin. Revenue growth remains solid, reaching $5.15B in 2025, though weak 2027 sales guidance has pressured the stock. A dividend of $0.66 is scheduled for payment in September 2026.
Outlook is mixed: strong fundamentals and a consensus price target of $235.70 suggest upside, but bearish technicals and investor lawsuits pose near-term risks. The stock offers value with a P/E of 21.19, yet competitive and regulatory challenges require monitoring for sustained growth.
SHOP trades at $134.1, down 7.57% in the past 24 hours, reflecting recent market pressure. The stock is near its 52-week low of $130.00, with technical indicators showing a bearish trend. Fundamentally, revenue grew to $11.56B in 2025, but the P/E ratio of 90.61 suggests a premium valuation. Recent news highlights AI initiatives and competitive comparisons, while earnings show mixed quarterly results with a miss in Q4 2025 but beats in Q1 and Q2 2026.
Outlook: Strong revenue growth and expanding gross merchandise volume support long-term potential, but high valuation and recent price decline pose near-term risks. Analyst consensus is bullish with a $167.50 price target, though competitive pressures and market volatility require careful monitoring for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Shopify Inc.
Shopify Inc. provides a cloud-based commerce platform. The Company offers a platform for merchants to create an omni-channel experience that helps showcase the merchant's brand.
Read more on SHOP →
